In BlCa tissues, CD4+ levels were significantly higher in pTa-pT1 patients, comparing with most aggressive tumors (Jóźwicki et al., 2016; Viveiros et al., 2022). This evidence concerns the gene CD4 and bladder transitional cell carcinoma.